Performance of a Deep-Learning Algorithm vs Manual Grading for Detecting Diabetic Retinopathy in India.


Journal

JAMA ophthalmology
ISSN: 2168-6173
Titre abrégé: JAMA Ophthalmol
Pays: United States
ID NLM: 101589539

Informations de publication

Date de publication:
01 Sep 2019
Historique:
pubmed: 14 6 2019
medline: 14 6 2019
entrez: 14 6 2019
Statut: ppublish

Résumé

More than 60 million people in India have diabetes and are at risk for diabetic retinopathy (DR), a vision-threatening disease. Automated interpretation of retinal fundus photographs can help support and scale a robust screening program to detect DR. To prospectively validate the performance of an automated DR system across 2 sites in India. This prospective observational study was conducted at 2 eye care centers in India (Aravind Eye Hospital and Sankara Nethralaya) and included 3049 patients with diabetes. Data collection and patient enrollment took place between April 2016 and July 2016 at Aravind and May 2016 and April 2017 at Sankara Nethralaya. The model was trained and fixed in March 2016. Automated DR grading system compared with manual grading by 1 trained grader and 1 retina specialist from each site. Adjudication by a panel of 3 retinal specialists served as the reference standard in the cases of disagreement. Sensitivity and specificity for moderate or worse DR or referable diabetic macula edema. Of 3049 patients, 1091 (35.8%) were women and the mean (SD) age for patients at Aravind and Sankara Nethralaya was 56.6 (9.0) years and 56.0 (10.0) years, respectively. For moderate or worse DR, the sensitivity and specificity for manual grading by individual nonadjudicator graders ranged from 73.4% to 89.8% and from 83.5% to 98.7%, respectively. The automated DR system's performance was equal to or exceeded manual grading, with an 88.9% sensitivity (95% CI, 85.8-91.5), 92.2% specificity (95% CI, 90.3-93.8), and an area under the curve of 0.963 on the data set from Aravind Eye Hospital and 92.1% sensitivity (95% CI, 90.1-93.8), 95.2% specificity (95% CI, 94.2-96.1), and an area under the curve of 0.980 on the data set from Sankara Nethralaya. This study shows that the automated DR system generalizes to this population of Indian patients in a prospective setting and demonstrates the feasibility of using an automated DR grading system to expand screening programs.

Identifiants

pubmed: 31194246
pii: 2734990
doi: 10.1001/jamaophthalmol.2019.2004
pmc: PMC6567842
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

987-993

Auteurs

Varun Gulshan (V)

Google Research, Mountain View, California.

Renu P Rajan (RP)

Aravind Eye Hospital, Madurai, India.

Kasumi Widner (K)

Google Research, Mountain View, California.

Derek Wu (D)

Google Research, Mountain View, California.

Peter Wubbels (P)

Verily Life Sciences, San Francisco, California.

Tyler Rhodes (T)

Shri Bhagwan Mahavir Vitreoretinal Services, Sankara Nethralaya, Chennai, Tamil Nadu, India.

Kira Whitehouse (K)

Verily Life Sciences, San Francisco, California.

Marc Coram (M)

Google Research, Mountain View, California.

Greg Corrado (G)

Google Research, Mountain View, California.

Kim Ramasamy (K)

Aravind Eye Hospital, Madurai, India.

Rajiv Raman (R)

Shri Bhagwan Mahavir Vitreoretinal Services, Sankara Nethralaya, Chennai, Tamil Nadu, India.

Lily Peng (L)

Google Research, Mountain View, California.

Dale R Webster (DR)

Google Research, Mountain View, California.

Classifications MeSH